Advertisement
UK markets close in 1 hour 5 minutes

  • FTSE 100

    8,051.55
    +11.17 (+0.14%)
     

  • FTSE 250

    19,558.78
    -160.59 (-0.81%)
     

  • AIM

    752.67
    -2.02 (-0.27%)
     

  • GBP/EUR

    1.1656
    +0.0011 (+0.09%)
     

  • GBP/USD

    1.2492
    +0.0030 (+0.24%)
     

  • Bitcoin GBP

    51,003.04
    -1,684.48 (-3.20%)
     

  • CMC Crypto 200

    1,374.94
    -7.63 (-0.55%)
     

  • S&P 500

    5,011.36
    -60.27 (-1.19%)
     

  • DOW

    37,823.78
    -637.14 (-1.66%)
     

  • CRUDE OIL

    82.33
    -0.48 (-0.58%)
     

  • GOLD FUTURES

    2,333.70
    -4.70 (-0.20%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • HANG SENG

    17,284.54
    +83.27 (+0.48%)
     

  • DAX

    17,824.24
    -264.46 (-1.46%)
     

  • CAC 40

    7,969.37
    -122.49 (-1.51%)
     
Stocks:

Trending tickers

Microsoft, Alphabet, Anglo American, IBM, Astrazeneca, Unilever and Sainsbury's

Smith & Nephew meets lower end of guidance range for 2017

Reuters - UK Focus

LONDON, Feb 8 (Reuters) - Artificial hip and knee maker Smith & Nephew (Frankfurt: 502816 - news) scraped into the bottom of its guidance range for 2017, with a 3 percent rise in revenue to $4.77 billion pounds and a 20 basis point increase in its trading margin, resulting in profit of $1.05 billion.

Chief Executive Olivier Bohuon, who plans to retire by the end of the year, said the company's knees franchise performed well in the year.

(Reporting by Paul Sandle; editing by Kate Holton)